Fortunately, the scientific community has responded with concerted research
activity aimed at addressing this shortfall; however, the successful translation
of basic scientific discoveries into novel treatments is a long, complex and
expensive process. The process becomes significantly more complicated when
dealing with diseases that disproportionally afflict poor and marginalized populations.

Despite a renewed effort over the last 10 years — largely driven through a huge
increase in philanthropic funding — the situation for those actively engaged in the
front line of the war against developing world diseases has not noticeably improved.
The continuing challenges that hinder scientific innovation from reaching the clinic
are complex, solvable, and are the focus of this Outlook.

Click here to request your free copy or access the Outlook free online for 6 months.

Nature Publishing Group is not responsible for the content of this e-mail, and anything written in this e-mail does not necessarily reflect the views of Nature Publishing Group. Please note that neither the e-mail address nor name of the sender have been verified.

Register to receive FREE Table of Contents e-alerts from Nature Publishing Group.

Nature Publishing Group's worldwide offices:
London • Paris • Munich • New Delhi • Tokyo • Melbourne • San Diego • San Francisco •
Washington • New York • Boston • Hong Kong • Gurgaon • Mexico City • Basingstoke

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.